Authors retract two statin papers, one with problems “too extensive to revise”

Researchers in China have retracted two 2016 papers about the possible use of a cholesterol-lowering agent to treat bleeding on the brain.

One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, and patient enrollment. The notice is signed by first author Hua Liu of the Nanjing Medical University in China.

Liu is also the first author of another recently retracted paper in Frontiers in Neuroscience, pulled for incorrectly categorizing patients.

The JNS retraction notice begins: Continue reading Authors retract two statin papers, one with problems “too extensive to revise”

Journal retracts gastric cancer study with multiple duplications, authors MIA

An oncology journal has decided to retract a 2012 paper on gastric cancer after discovering duplicated data in multiple figures.

According to the retraction notice, the journal’s editorial board received a tip from a reader regarding the potential figure issues. Oncology Reports launched an investigation, which confirmed the allegations. The authors failed to respond to the journal’s multiple requests for more information.

Here’s the retraction notice: Continue reading Journal retracts gastric cancer study with multiple duplications, authors MIA

Authors retract tanning-UV radiation study for lacking approval

Researchers have agreed to pull a 2015 study exploring whether a plant extract can safeguard tanners from ultraviolet exposure after not obtaining formal approval from an ethics committee.

According to the first author, the problem lay in a misunderstanding – when they originally applied for approval six years ago, the researchers believed they didn’t need to go through a formal approval process, since the compound was commercially available without a prescription. Once they realized their mistake, they chose to retract the paper.

Here’s the retraction note for “Oral Polypodium leucomotos increases the anti-inflammatory and melanogenic responses of the skin to different modalities of sun exposures: a pilot study,” published in Photodermatology Photoimmunology & PhotomedicineContinue reading Authors retract tanning-UV radiation study for lacking approval

Journal retracts surgery study with data “not intended for use in research”

A journal has retracted a surgery study by researchers at Brown University after noticing it included data that was not intended for research purposes. (Incidentally, the data were collected by the publisher of the journal.)

Ingrid Philbert, managing editor of the Journal of Graduate Medical Education — which published the paper — told Retraction Watch that senior staff at the publisher alerted the journal that they suspected the authors had used data from a confidential source:

This is a fairly new set of case log data, and as the collector [of] the data, the [Accreditation Council for Graduate Medical Education (ACGME)] gets to determine the use and it has decreed that this data be used solely for accreditation decisions.

Philbert said the journal asked the authors where they got the data:

Continue reading Journal retracts surgery study with data “not intended for use in research”

Japan group earns 4th retraction following investigation

Researchers in Japan have issued their fourth retraction, noting that the same figures were used to depict different experimental conditions.

The group lost two papers in 2015 for the same reason, following a misconduct investigation at Oita University in Japan. Last year, the same group notched another retraction, and pegged the responsibility for the problematic figures on first author Satoshi Hagiwara.

Now, the group has published a fourth retraction in the European Journal of Pharmacologythe latest notice doesn’t identify a culprit. All four retracted papers list Hagiwara as first author.

Here’s the latest retraction notice: Continue reading Japan group earns 4th retraction following investigation

Plant journal flags fungus paper amid investigation

A journal has issued an expression of concern (EOC) for a recently published study after a probe identified “problems with the figure presentation.”

According to the EOC notice in New Phytologist, two figures in the paper contained “some anomalies,” and the corresponding author has acknowledged that there are problems with the images.

Here’s the EOC notice: Continue reading Plant journal flags fungus paper amid investigation

Authors use same images in two studies — one is retracted, the other flagged by journal

After researchers in China included the same images in two papers published online one month apart, one paper has been retracted, and the other flagged with an expression of concern. 

According to the retraction notice in the International Journal of Molecular Medicine (IJMM), the authors intended that the two different papers offered “different research perspectives.”

Meanwhile, the Chinese Medical Journal — which published the same images one month later — has issued an expression of concern (EOC), noting it “should not be considered as a statement regarding the validity of the work.” Both papers describe how cells regulate blood flow to the retina.

Normally, journals choose to retract the most recent paper containing duplicated images, but in this case, the IJMM paper was published online in February 2016, and the Chinese Medical Journal in March.

Here’s the retraction notice: Continue reading Authors use same images in two studies — one is retracted, the other flagged by journal

“My time and energy were stolen:” Peer reviewer reacts to retraction

Martha Alibali

When a former Stanford psychology researcher lost her fifth paper last year due to unreliable results, one researcher took particular notice: Martha Alibali at the University of Wisconsin-Madison. Why? She had reviewed the 2006 paper, and took to social media to express her dismay at the result of the time and effort she spent on the research. We spoke with Alibali further about her reactions to the news.

Retraction Watch: You reviewed the paper more than 10 years ago. Can you recall what you thought about it? In retrospect, were there any red flags or doubts you had about the findings that you wish you’d caught?

Continue reading “My time and energy were stolen:” Peer reviewer reacts to retraction

Researcher loses 4th paper flagged by misconduct probe

A researcher in Germany has logged her fourth retraction following an investigation by her former employer that found evidence of scientific misconduct.

The latest retraction for Tina Wenz in the Journal of Applied Physiology mentions the probe at the University of Cologne in Germany, which recommended retracting six of her papers. One had already been retracted by the time the report was released; last month, we reported that two others had been pulled. Now, we’ve come across a fourth.

Here’s the latest retraction notice: Continue reading Researcher loses 4th paper flagged by misconduct probe

JAMA article on zinc for the common cold retracted

Authors have retracted a JAMA article summarizing the evidence behind the benefits of a supplement, after the systemic review upon which it was based was withdrawn.

The 2014 paper, “Oral Zinc for the Common Cold,” drew from a 2013 Cochrane Review, considered the gold standard for rigorous analyses of clinical treatments. That Cochrane review was withdrawn last year, a decision that the editors upheld this past September. Both were co-authored by Rashmi Ranjan Das, of the All India Institute of Medical Sciences, in Bhubaneswar, and Meenu Singh, of the Post-Graduate Institute of Medical Education and Research, in Chandigarh, India.

JAMA editor in chief Howard Bauchner told Retraction Watch that this week’s retraction followed an investigation by the journal: Continue reading JAMA article on zinc for the common cold retracted